Patch Offers a New Approach for Treating Iron Deficiency

Patch-like wearables are becoming increasingly popular in medtech. The latest device to employ such a design and make medtech headlines is transdermal patch being developed by Fe3 Medical. San Antonio, TX-based Fe3 said its biphasic iontophoretic transdermal technology is for the treatment of iron deficiency anemia. The firm announced results from its first human study of the patch-like device. The human study focused on the safety and tolerability of Fe3's iontophoretic transdermal technology designed to bypass ionic resistance build up in the skin. The human study follows a series of successful preclinical studies demonstrating the safe delivery of iron through the skin. The firm’s technology is designed as an alternative therapy for the millions of patients who suffer from debilitating effects of iron deficiency anemia but cannot tolerate the current oral therapies available. Fe3’s human study was conducted at a Clinical Research Organization (CRO) in Texas, under Investigational Review Board (IRB) approval. The company conducted safety and tolerability studies, evaluating iron transport with Fe3's proprietary transdermal platform in forty healthy volunteers. After mild skin preparation, the Fe3 patch was applied to the thigh of the subject. The patch was programmed for a short hydration interval followed by about five hours of active therapy. The study demonstrated successful iron transport, with a rapid rise in serum iron levels during...
Source: MDDI - Category: Medical Devices Authors: Tags: Adhesives Source Type: news